LA | |
---|---|
Post | 6.2 |
Pre | 3.5 |
M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|
0 | - | - | - | - | 1.2 | 110.2 | 66.5 | - | - | - | 178.0 |
1 | - | - | - | - | - | 17.0 | 8.2 | 0.5 | - | - | 25.8 |
LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
---|---|---|---|---|---|---|---|---|
Post | - | - | - | - | - | - | - | - |
Pre | - | - | - | - | - | - | - | - |
AME | |
---|---|
0 | 46.8 |
1 | 7.2 |
LOP1 | LOP2 | LOP3 | LOP4 | Total | |
---|---|---|---|---|---|
Post | - | - | - | - | - |
Pre | - | - | - | - | - |
central brain | |
---|---|
0 | - |
1 | - |
Number of post synapses: 712
Number of pre synapses: 103
Number of output connections: 187
Coverage factor: 1.2
Columnar completeness: 0.15
Area completeness: 0.20
Cell size (columns): 29
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
instance | NT | total connections | connections /#Lat3 (R) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | aMe17a (R) | Glu | 158 | 39.5 | 15.1% | 15.1% |
1 | MeVP45 (R) | ACh | 94 | 23.5 | 9.0% | 24.1% |
2 | Lat3 (R) | unclear | 76 | 19.0 | 7.3% | 31.3% |
3 | MeVC3 (L) | ACh | 73 | 18.2 | 7.0% | 38.3% |
4 | Cm34 (R) | Glu | 62 | 15.5 | 5.9% | 44.2% |
5 | aMe12 (R) | ACh | 58 | 14.5 | 5.5% | 49.8% |
6 | aMe26 (R) | ACh | 40 | 10.0 | 3.8% | 53.6% |
7 | Cm31b (R) | GABA | 33 | 8.2 | 3.2% | 56.7% |
8 | aMe2 (R) | Glu | 32 | 8.0 | 3.1% | 59.8% |
9 | Mi10 (R) | ACh | 32 | 8.0 | 3.1% | 62.8% |
10 | MeVP1 (R) | ACh | 30 | 7.5 | 2.9% | 65.7% |
11 | MeVC20 (R) | Glu | 21 | 5.2 | 2.0% | 67.7% |
12 | 5thsLNv_LNd6 (R) | ACh | 17 | 4.2 | 1.6% | 69.3% |
13 | aMe22 (R) | Glu | 17 | 4.2 | 1.6% | 71.0% |
14 | CL125 (R) | unclear | 17 | 4.2 | 1.6% | 72.6% |
15 | aMe17b (R) | GABA | 16 | 4.0 | 1.5% | 74.1% |
16 | Cm1 (R) | ACh | 15 | 3.8 | 1.4% | 75.5% |
17 | Cm5 (R) | GABA | 14 | 3.5 | 1.3% | 76.9% |
18 | Cm20 (R) | GABA | 12 | 3.0 | 1.1% | 78.0% |
19 | Mi15 (R) | ACh | 12 | 3.0 | 1.1% | 79.2% |
20 | Dm2 (R) | ACh | 11 | 2.8 | 1.1% | 80.2% |
21 | Cm8 (R) | GABA | 10 | 2.5 | 1.0% | 81.2% |
22 | MeTu1 (R) | ACh | 10 | 2.5 | 1.0% | 82.1% |
23 | Cm24 (R) | Glu | 9 | 2.2 | 0.9% | 83.0% |
24 | Lat1 (R) | unclear | 9 | 2.2 | 0.9% | 83.9% |
25 | Cm3 (R) | GABA | 8 | 2.0 | 0.8% | 84.6% |
26 | MeVC27 (L) | unclear | 7 | 1.8 | 0.7% | 85.3% |
27 | Tm29 (R) | Glu | 7 | 1.8 | 0.7% | 86.0% |
28 | aMe4 (R) | ACh | 6 | 1.5 | 0.6% | 86.5% |
29 | aMe12 (L) | ACh | 5 | 1.2 | 0.5% | 87.0% |
30 | Cm17 (R) | GABA | 5 | 1.2 | 0.5% | 87.5% |
31 | Cm31a (R) | GABA | 5 | 1.2 | 0.5% | 88.0% |
32 | DNpe053 (R) | ACh | 5 | 1.2 | 0.5% | 88.4% |
33 | MeTu3c (R) | ACh | 5 | 1.2 | 0.5% | 88.9% |
34 | OA-AL2i4 (R) | OA | 5 | 1.2 | 0.5% | 89.4% |
35 | aMe1 (R) | GABA | 4 | 1.0 | 0.4% | 89.8% |
36 | aMe5 (R) | ACh | 4 | 1.0 | 0.4% | 90.2% |
37 | Cm6 (R) | GABA | 4 | 1.0 | 0.4% | 90.5% |
38 | Dm9 (R) | Glu | 4 | 1.0 | 0.4% | 90.9% |
39 | OA-AL2i3 (R) | OA | 4 | 1.0 | 0.4% | 91.3% |
instance | NT | total connections | connections /#Lat3 (R) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | Lat3 (R) | unclear | 76 | 19.0 | 21.4% | 21.4% |
1 | Cm9 (R) | Glu | 17 | 4.2 | 4.8% | 26.2% |
2 | Cm35 (R) | GABA | 12 | 3.0 | 3.4% | 29.6% |
3 | Cm34 (R) | Glu | 11 | 2.8 | 3.1% | 32.7% |
4 | R1-R6 (R) | His | 11 | 2.8 | 3.1% | 35.8% |
5 | aMe10 (R) | ACh | 10 | 2.5 | 2.8% | 38.6% |
6 | Cm11c (R) | ACh | 10 | 2.5 | 2.8% | 41.4% |
7 | aMe15 (R) | unclear | 8 | 2.0 | 2.3% | 43.7% |
8 | aMe4 (R) | ACh | 8 | 2.0 | 2.3% | 45.9% |
9 | MeVP59 (R) | ACh | 7 | 1.8 | 2.0% | 47.9% |
10 | aMe26 (R) | ACh | 6 | 1.5 | 1.7% | 49.6% |
11 | Cm20 (R) | GABA | 6 | 1.5 | 1.7% | 51.3% |
12 | L1 (R) | Glu | 6 | 1.5 | 1.7% | 53.0% |
13 | Cm10 (R) | GABA | 5 | 1.2 | 1.4% | 54.4% |
14 | Cm14 (R) | GABA | 5 | 1.2 | 1.4% | 55.8% |
15 | Cm3 (R) | GABA | 5 | 1.2 | 1.4% | 57.2% |
16 | MeTu1 (R) | ACh | 5 | 1.2 | 1.4% | 58.6% |
17 | MeVP45 (R) | ACh | 5 | 1.2 | 1.4% | 60.0% |
18 | Dm2 (R) | ACh | 4 | 1.0 | 1.1% | 61.1% |
19 | MeLo6 (R) | ACh | 4 | 1.0 | 1.1% | 62.3% |
20 | MeTu3b (R) | ACh | 4 | 1.0 | 1.1% | 63.4% |
21 | MeVP9 (R) | ACh | 4 | 1.0 | 1.1% | 64.5% |
22 | MeVPMe5 (L) | Glu | 4 | 1.0 | 1.1% | 65.6% |
23 | Tm5c (R) | Glu | 4 | 1.0 | 1.1% | 66.8% |